Cargando…
“Biosimilar, so it looks alike, but what does it mean?” A qualitative study of Danish patients' perceptions of biosimilars
Biosimilars are highly similar follow‐on products for biologics that can foster biologics competition. Questionnaire studies have attempted to gauge the patient perspective on biosimilars, but none have delved deeper into how patients view biologics and switching of these. Considering Denmark has on...
Autores principales: | Varma, Meera, Almarsdóttir, Anna Birna, Druedahl, Louise C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314148/ https://www.ncbi.nlm.nih.gov/pubmed/35261174 http://dx.doi.org/10.1111/bcpt.13719 |
Ejemplares similares
-
Interchangeability of biosimilars: A study of expert views and visions regarding the science and substitution
por: Druedahl, Louise C., et al.
Publicado: (2022) -
Overcoming Barriers to the Market Access of Biosimilars in the European Union: The Case of Biosimilar Monoclonal Antibodies
por: Moorkens, Evelien, et al.
Publicado: (2016) -
Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care
por: Vandenplas, Yannick, et al.
Publicado: (2022) -
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
por: Mysler, Eduardo, et al.
Publicado: (2021) -
Key concepts in biosimilar medicines: What physicians must know
por: Iskit, Alper B.
Publicado: (2022)